Related Experiment Videos
The immune response to HIV: potential for immunotherapy?
1Dept of Cellular and Molecular Sciences, St George's Hospital Medical School, London, UK.
Immunology Today
|July 1, 1995
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Effect of Gemcitabine based chemotherapy on the immunogenicity of pancreatic tumour cells and T-cells.
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2020
The T4 molecule: function and structure.
Immunology today·2014
Treatment patterns, outcomes, and resource utilization of patients with metastatic melanoma in the U.K.: the MELODY study.
The British journal of dermatology·2013
Supernatants derived from chemotherapy-treated cancer cell lines can modify angiogenesis.
British journal of cancer·2012
Anti-tumour activity of afatinib, an irreversible ErbB family blocker, in human pancreatic tumour cells.
British journal of cancer·2011
The origin and significance of anti-DNA antibodies.
Immunology today·2014
Mutations of class II MHC molecules.
Immunology today·2014
Antigen processing at the molecular level.
Immunology today·2014
Phenotypically and functionally distinct T-cell subsets in anti-tumor responses.
Immunology today·2014
Are MHC class II-restricted cytotoxic T lymphocytes important?
Immunology today·2014
Complement and the regulation of humoral immune responses.
Immunology today·2014
Regulatory T cells in the skin: Origin, function, and plasticity.
JID innovations : skin science from molecules to population health·2026
Engineered GLUT1-targeted STING polyproagonists: Redox-triggered activation and enhanced endosomal escape for cancer immunotherapy.
Asian journal of pharmaceutical sciences·2026
Lactate-Induced K370 Lactylation of STING Inhibits STING-TBK1 Signaling and Dampens Anti-Tumor Immunity.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Biomarkers in Irritable Bowel Syndrome: Bridging Gut-Brain Mechanisms to Precision Care.
Current gastroenterology reports·2026